Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AstraZeneca lung cancer drug delays disease by more than a year

An experimental lung cancer pill from AstraZeneca delays disease progression by more than a year, according to new data presented at a medical meeting on Friday. AZD9291, which the company expects to file for U.S. approval in the second quarter of 2015, is one of a number of cancer medicines AstraZeneca is hoping will rebuild […]

Read More »

Real World Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC

AstraZeneca today presented results from two key studies showing the effectiveness of plasma circulating tumour DNA (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation status in newly diagnosed patients with advanced non-small cell lung cancer (NSCLC) in clinical practice.[1],[2] Data from the studies – ASSESS and IGNITE – were reported at the European Lung […]

Read More »

ThromboGenics and VIB Form New Company to Research Roche-Rejected Cancer Drug

ThromboGenics NV (TBGNF), a biopharmaceutical company based in Leuven, Belgium, announced that it is teaming up with VIB, a life sciences institute in Flanders (Belgium), to found Oncurious NV, an oncology company.  Oncurious will focus on developing TB-403 for the treatment of pediatric brain tumors. TB-403 is a monoclonal antibody that opposes placental growth factor (PIGF). PIGF is observed in several […]

Read More »

FDA panel votes in favor of Medicines Co’s blood clot preventer

The Medicines Co’s intravenous blood clot preventer can be used in angioplasty procedures, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 9-2 to support the approval of the once-rejected injection, cangrelor, for use in some patients undergoing angioplasty, a procedure to widen narrowed or clogged coronary […]

Read More »

Snoring, apnea linked to earlier memory decline in elderly

Older people who have sleep apnea, which can be marked by heavy snoring, tend to begin experiencing cognitive decline about ten years earlier than those without the disorder, or those who use a breathing machine to treat their apnea, according to a new U.S. study. Among older people who developed mild cognitive impairment or Alzheimer’s […]

Read More »

U.S. study calls into question tests that sequence tumor genes

  (Reuters) – New cancer tests that sequence only a patient’s tumor and not normal tissue could result in a significant number of false positive results, potentially leading doctors to prescribe treatments that might not work, U.S. researchers said on Wednesday.   The findings, published in the journal Science Translational Medicine, call into question the […]

Read More »

What Five Days Of Eating Fatty Foods Does To Your Muscles, Virginia Tech Study

Five Days Of Eating Fatty Foods Can Alter How Your Body’s Muscle Processes Food BLACKSBURG, Va., April 13, 2015 – You might think that you can get away with eating fatty foods for a few days without it making any significant changes to your body. Think again. After just five days of eating a high-fat […]

Read More »

Gestational Diabetes May Boost Autism Risk, Study

Intrauterine Exposure To Maternal Gestational Diabetes Associated With Increased Risk Of Autism Among a group of more than 320,000 children, intrauterine exposure to gestational diabetes mellitus diagnosed by 26 weeks’ gestation was associated with risk of autism spectrum disorders (ASDs), according to a study in the April 14 issue of JAMA. Maternal pre-existing type 2 […]

Read More »

Bayer HealthCare Invests $100 Million in East Bay Facility to Double Down on Hemophilia Drugs

April 14, 2015By Mark Terry, Breaking News Staff Bayer HealthCare, a division of Germany-based Bayer AG (BAYZF), announced today that it will spend $100 million to expand its facilities near its campus in East Bay San Francisco. The new building will be 80,000-square-feet in size and will replace an older facility. The new build […]

Read More »

Weight loss linked to bone loss in middle aged women

(Reuters Health) – Losing weight in middle age may mean losing not just unwanted fat, but also precious bone density, at least for women, a new U.S. study suggests.   Regardless of the types of foods or amount of calcium in their diets, middle aged women who lost a moderate amount of weight over a […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom